<DOC>
	<DOCNO>NCT02606552</DOCNO>
	<brief_summary>Comparatively analyze safety validity Amplazter Cardiac Plug ( ACP ) device-using percutaneous leave atrial appendage closure , medical treatment dabigatran plus aspirin dabigatran plus clopidogrel 3months triple therapy ( Dabigatran plus DAPT ( dual-antiplatelet therapy ) ) patient coronary artery disease treat drug-eluting stent , accompany atrial fibrillation . Total 670 patient [ leave atrial appendage occlusion registry 100 ACP/ 570 anti-coagulation registry : ( 285 Dabigatran plus aspirin ) ( 285 Dabigatran plus clopidogrel ) therapy ) ] comparatively analyzed safety efficacy . Primary endpoint composite death , non-fatal myocardial infarction , stroke , systemic embolism , GUSTO bleeding ( moderate severe ) .</brief_summary>
	<brief_title>Safety Efficacy Left Atrial Appendage Closure Versus Antithrombotic Therapy Patients With Atrial Fibrillation Undergoing Drug-Eluting Stent Implantation Due Complex Coronary Artery Disease</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Dabigatran</mesh_term>
	<criteria>1 . Patients older 20 year accompany chronic atrial fibrillation CHADS2 score â‰¥2 2 . Patients coronary artery disease ( require DES ) receive 2nd generation drugeluting stent insertion treatment 3 . Subjects legal representative must understand main purpose study , agree relevant provision , sign consent form approve IRBs institution . 4 . Subjects agree followup study ( coronary angiography ) transesophageal echocardiography , etc . 5 . Subjects agree follow request postoperative followup visit . 1 . Patients show hypersensitive reaction reason restriction aspirin , heparin , clopidogrel , warfarin , otherwise , susceptible contrast medium , therefore , could use drug pregnant breast feeding . 2 . Comorbidities atrial fibrillation require chronic warfarin use . 3 . Patients diagnose progressive infection condition endocarditis . 4 . Patients diagnose progressive gastric ulcer upper gastrointestinal bleeding last 3 month . 5 . Hemodynamically unstable patient need inotropic support . 6 . Senile dementia patient experience cerebrovascular accident ( CVA ) last 6 week . 7 . Patients diagnose intracardiac mass , thrombus , vegetation echocardiographic finding . 8 . Patients diagnose severe leave ventricular dysfunction ( &lt; LVEF 30 % ) . 9 . Patients blood disorder following : leucopenia ( &lt; WBC 3,000mm3 ) , acute anemia ( &lt; Hg 9mg % ) , Thrombocytopenia ( &lt; 100,000 platelets/mm3 ) , evidence bleed clot disorder . 10 . Patients show life expectancy le 12 month noncardiac comorbidities . 11 . Patients severe vein occlusion femoral vein , ceiling vein , inferior vena cava . 12 . A patent foramen ovale atrial septal aneurysm righttoleft shunt 13 . Symptomatic carotid artery disease 14 . Patients severe valvular heart disease 15 . Patients currently participate clinical trial drug medical device .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>drug elute stent</keyword>
	<keyword>atrial appendage closure</keyword>
</DOC>